Context sidebar
03.04.2020
COVID-19: Deadline extension
01.04.2020
ZL109_00_001e_WL
26.03.2020
Independent experts as an additional quality-assurance element in the authorisation process
25.02.2020
Swissmedic authorises a new active substance (NAS) under the ACSS Consortium initiative for the first time
01.02.2020
The new version of the guidance document enters into force on 1 February 2020.
20.01.2020
There are two versions of Swissmedic's templates for Information for healthcare professionals and Patient information for human medicinal products
15.01.2020
Changed procedure for "Justified cases" pursuant to Art. 18 para. 2 TPO
01.01.2020
ZL000_00_043e_WL
19.12.2019
ZL003_00_001de_SD
01.12.2019
ZL000_00_024e_WL / ZL101_00_007e_WL / ZL300_00_001e_WL
05.11.2019
29.10.2019
ZL000_00_006e_VZ
ZL300_00_003e_FO
ZL000_00_020e_WL
22.10.2019
ZL000_00_048d_VL / ZL000_00_049d_VL
Allocation of IT groups to Case Management (XLS, 251 kB, 01.02.2020)
Top of page
